Effects of Radiofrequency Ablation of Posterior Nasal Nerves on Inflammatory Cytokines, Peak Nasal Inspiratory Flow, and Nasal Blood Flow in Patients With Chronic Rhinitis

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

February 20, 2024

Study Completion Date

February 20, 2024

Conditions
Chronic Rhinitis
Interventions
DEVICE

Radiofrequency ablation (RFA)

The NEUROMARK device is an in-office, disposable bipolar RFA device with a treatment tip consisting of micro electrodes which delivers RF energy while monitoring appropriate tissue contact to maximize delivery to posterior nasal nerve and its variable branching. After topical anesthesia consisting of oxymetazoline and 1% lido followed by 4% lidocaine, the device will be placed in the posterior inferior turbinate under endoscopic visualization. The device will be activated per manufacturer's instructions

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
collaborator

American Academy of Otolaryngic Allergy

OTHER

lead

The University of Texas Health Science Center, Houston

OTHER